Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States.

Kim, Sunnie

Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States. [electronic resource] - Advances in therapy 10 2018 - 1564-1577 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1865-8652

10.1007/s12325-018-0784-z doi


Adenocarcinoma--drug therapy
Aged
Albumins--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cohort Studies
Deoxycytidine--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Irinotecan--administration & dosage
Leucovorin--administration & dosage
Male
Middle Aged
Neoplasm Staging
Oxaliplatin--administration & dosage
Paclitaxel--administration & dosage
Pancreatic Neoplasms--drug therapy
Retrospective Studies
Survival Analysis
Treatment Outcome
United States--epidemiology
Gemcitabine